Caption Management, LLC Cerus Corp Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.9 $15,293 - $24,777	8,544 Added 44.97%	27,544 $67,000
Q1 2023 May 15, 2023	SELL	$2.65 - $3.81 $8,835 - $12,702	-3,334 Reduced 14.93%	19,000 $56,000
Q4 2022 Feb 14, 2023	BUY	$3.38 - $4.22 $41,688 - $52,049	12,334 Added 123.34%	22,334 $81,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $34,300 - $58,300	10,000 New	10,000 $36,000
Q1 2022 May 13, 2022	SELL	$4.81 - $6.99 $76,960 - $111,840	-16,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $76,640 - $106,880	16,000 New	16,000 $97,000
Q4 2019 Feb 13, 2020	SELL	$3.84 - $4.86 $110,208 - $139,482	-28,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.86 - $6.05 $139,482 - $173,635	28,700 New	28,700 $148,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.